Efficacy and Safety of Acotiamide Versus Mosapride in Patients With Functional Dyspepsia Associated With Meal-Induced Postprandial Distress Syndrome: A Phase III Randomized Clinical Trial

Background: Acotiamide is a novel prokinetic drug that acts by enhancing the release of acetylcholine and is used in the treatment of functional dyspepsia-postprandial distress syndrome (FD-PDS). Mosapride is indicated to FD-PDS as per the Rome III treatment guidelines. Mosapride 5 mg three times da...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Shubhadeep, Chary, Sreenivasa, Thakur, Pankaj, Talluri, Leela, Reddy, Mohan, K, Gautam S, Mohan, Jagan M, Jain, Pankaj, Naik, Sunil, C. Reddy, Srinivas V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526522/
https://www.ncbi.nlm.nih.gov/pubmed/34692320
http://dx.doi.org/10.7759/cureus.18109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526522/
https://www.ncbi.nlm.nih.gov/pubmed/34692320
http://dx.doi.org/10.7759/cureus.18109

Ejemplares similares